autologous blood transfusion

Autologous blood transfusion is a medical procedure involving the collection and subsequent re-infusion of a patient's own blood or blood components. This technique is primarily utilized in clinical settings to reduce the need for allogenic (homologous) blood, thereby mitigating risks such as transfusion-transmitted infections, hemolytic reactions, and alloimmunization. In the specific research context associated with Hamad Medical Corporation, autologous transfusion is being investigated as a method of blood doping in athletes. The study focuses on developing advanced detection techniques, such as DNA-typing and erythrocyte microparticle (RBC-MP) analysis, to distinguish between legitimate medical use and illicit performance enhancement achieved by increasing red blood cell mass and oxygen-carrying capacity.

Other names

autologous transfusionautotransfusionautologous blood re-infusion